Cited by 1,492Cancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer

The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Open access

Tie, Jeanne, Wang, Yuxuan, Tomasetti, Cristian, Li, Lu, Springer, Simeon, Kinde, Isaac, Silliman, Natalie, Tacey, Mark, Wong, Hui-Li, Christie, Michael, Kosmider, Suzanne, Skinner, Iain, Wong, Rachel, Steel, Malcolm, Tran, Ben, Desai, Jayesh, Jones, Ian, Haydon, Andrew, Hayes, Theresa, Price, Tim J., Strausberg, Robert L., Diaz, Luis A., Papadopoulos, Nickolas, Kinzler, Kenneth W., Vogelstein, Bert, Gibbs, Peter·2016·Science Translational Medicine

DOI 10.1126/scitranslmed.aaf6219PMC PMC5346159

Open this paper in CoChat — free account

Abstract

Detection of circulating tumor DNA in patients with resected stage II colon cancer provides evidence of residual disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaf6219

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citation
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Self-citation
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746
Self-citation
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Self-citation
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623

Show all 43 references

Research works printed but not linked: 1

S. Edge D. R. Byrd C. C. Compton A. G. Fritz F. L. Greene A. Trotti AJCC Cancer Staging Manual (Springer New York 2010) 648 pp.

Sorted by citations

Items 401–500 of 1,001

Methylation status and long‐fragment cell‐free DNA are prognostic biomarkers for gastric cancer
Ko, K., Kananazawa, Y., Yamada, T., Kakinuma, D., MATSUNO, K., Ando, F., Kuriyama, S., Matsuda, A., & Yoshida, H. (2021) · Cancer Medicine · doi:10.1002/cam4.3755 · Cited by 39
How I treat stage II colon cancer patients
Taı̈eb, J., Karoui, M., & Basile, D. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100184 · Cited by 39
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)
Folprecht, G., Reinacher‐Schick, A., Weitz, J., Lugnier, C., Kraeft, A., Wisser, S., Aust, D. E., Weiß, L., von Bubnoff, N. C. C., Krämer, M., et al. (2021) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2021.09.005 · Cited by 40
Updates of liquid biopsy in oral cancer and multiomics analysis
Zhang, X., & Li, B. (2021) · Oral Diseases · doi:10.1111/odi.14064 · Cited by 39
Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer
Morris, V. K., Overman, M. J., Lam, M., Parseghian, C. M., Johnson, B., Dasari, A., Raghav, K., Kee, B. K., Huey, R., Wolff, R. A., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0194 · Cited by 38
Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma
Krumbholz, M., Eiblwieser, J., Ranft, A., Zierk, J., Schmidkonz, C., Stütz, A. M., Peneder, P., Tomazou, E. M., Agaimy, A., Bäuerle, T., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1324 · Cited by 39
Using all our genomes: Blood‐based liquid biopsies for the early detection of cancer
Adams, E. W., Sepich‐Poore, G. D., Miller‐Montgomery, S., & Knight, R. D. (2022) · Open Research (University of Surrey) · doi:10.1002/viw.20200118 · Cited by 38
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism
Jee, J., Brannon, A. R., Singh, R. K., Derkach, A., Fong, C. J., Lee, A. V., Gray, L., Pichotta, K., Luthra, A., Diosdado, M. S., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03195-0 · Cited by 42
The cancer bloodhounds
Webb, S. (2016) · Nature Biotechnology · doi:10.1038/nbt.3717 · Cited by 38
Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With Cancer
Borad, M. J., & LoRusso, P. M. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.08.002 · Cited by 38
Circulating tumor DNA testing in advanced non-small cell lung cancer
Moding, E. J., Diehn, M., & Wakelee, H. A. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.02.019 · Cited by 38
Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review
Červená, K., Vodička, P., & Vymetalkova, V. P. (2019) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2019.05.002 · Cited by 42
Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer
Zhang, X., Ju, S., Wang, X., & Cong, H. (2019) · Clinical and Experimental Medicine · doi:10.1007/s10238-019-00563-w · Cited by 38
Hypoxia differently modulates the release of mitochondrial and nuclear DNA
Otandault, A., Abraham, J.-D., Dache, Z. A. A., Khalyfa, A., Jariel‐Encontre, I., Forné, T., Prévostel, C., Chouaïb, S., Gozal, D., & Thierry, A. R. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0716-y · Cited by 41
Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis
He, Y., Ma, X., Chen, K., Liu, F., Cai, S., Han‐Zhang, H., Hou, T., Xiang, J., & Peng, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s240869 · Cited by 37
ctDNA on liquid biopsy for predicting response and prognosis in locally advanced rectal cancer: A systematic review
Morais, M., Pinto, D. M., Machado, J. C., & Carneiro, S. (2021) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2021.08.034 · Cited by 38
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis
Angeles, A. K., Christopoulos, P., Yuan, Z. K., Bauer, S., Janke, F., Ogrodnik, S. J., Reck, M., Schlesner, M., Meister, M. A., Schneider, M. A., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00239-3 · Cited by 38
Liquid biopsies in cancer
Yin, H., Zhang, M., Zhang, Y., Zhang, X., Zhang, B., & Zhang, B. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00257-8 · Cited by 41
Clinical prospects of liquid biopsies
Alix‐Panabières, C., & Pantel, K. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0065 · Cited by 37
Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer
von Bubnoff, N. C. C. (2017) · Oncology Research and Treatment · doi:10.1159/000478864 · Cited by 38
The role of liquid biopsy in predicting post-operative recurrence of non-small cell lung cancer
Liang, H., Huang, J., Wang, W., Liu, Z., He, J., & Liang, W. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.04.08 · Cited by 38
Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA
Benešová, L., Hálková, T., Ptáčková, R., Semyakina, A., Menclová, K., Pudil, J., Ryska, M., Levý, M., Šimša, J., Pazdírek, F., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i48.6939 · Cited by 36
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer
Tarazona, N., Gimeno-Valiente, F., Gambardella, V., Huerta, M., Roselló, S., Zúñiga, S., Calon, A., Carbonell‐Asins, J. A., Fontana, E., Martínez‐Ciarpaglini, C., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000847 · Cited by 37
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
Heidrich, I., Abdalla, T. S. A., Reeh, M., & Pantel, K. (2021) · Cancers · doi:10.3390/cancers13184500 · Cited by 38
Liquid biopsy for early cancer detection: technological revolutions and clinical dilemma
Fu, S. W., Tang, C., Tan, X., & Srivastava, S. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2408744 · Cited by 41
Liquid biopsies in lung cancer—time to implement research technologies in routine care?
Köhn, L., Johansson, M., Grankvist, K., & Nilsson, J. A. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.12 · Cited by 36
Liquid Biopsy in Colorectal Cancer-Current Status and Potential Clinical Applications
Norčič, G. (2018) · Micromachines · doi:10.3390/mi9060300 · Cited by 37
Clinical implementation and current advancement of blood liquid biopsy in cancer
Watanabe, K., Nakamura, Y., & Low, S. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00939-5 · Cited by 37
Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer
Abdalla, T. S. A., Meiners, J., Riethdorf, S., König, A., Melling, N., Gorges, T. M., Karstens, K.-F., Izbicki, J. R., Pantel, K., & Reeh, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252897 · Cited by 36
Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
Maravelia, P., Silva, D. N., Rovesti, G., Chrobok, M., Stal, P. I., Lu, Y., & Pasetto, A. (2021) · Cancers · doi:10.3390/cancers13174334 · Cited by 38
ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)
Slater, S., Bryant, A., Chen, H.-C., Begum, R., Rana, I., Aresu, M., Peckitt, C., Zhitkov, O., Lazaro-Alcausi, R., Borja, V., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-10699-4 · Cited by 37
Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities
Lee, B., Gately, L., Lok, S. W., Tran, B., Lee, M., Wong, R., Markman, B., Dunn, K., Wong, V., Loft, M., et al. (2022) · Cancers · doi:10.3390/cancers14174131 · Cited by 37
Self-citation
Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer
Ryoo, S., Heo, S., Lim, Y., Lee, W., Cho, S. H., Ahn, J., Kang, J., Kim, S. Y., Kim, H., Bang, D., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02300-3 · Cited by 35
Circulating Tumor DNA in the Management of Early-Stage Breast Cancer
Vlataki, K., Antonouli, S., Kalyvioti, C., Lampri, E. S., Kamina, S., Mauri, D., Harissis, H. V., & Magklara, A. (2023) · Cells · doi:10.3390/cells12121573 · Cited by 34
The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
Saluja, H., Karapetis, C. S., Pedersen, S. K., Young, G. P., & Symonds, E. L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00275 · Cited by 35
The Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources
Mathé, E. A., Hays, J. L., Stover, D. G., & Chen, J. L. (2018) · Yearbook of Medical Informatics · doi:10.1055/s-0038-1667085 · Cited by 33
Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology
Bastiaenen, V. P., Jakobsen, I. H., Labianca, R., Martling, A., Morton, D. G., Primrose, J. M., Tanis, P. J., & Laurberg, S. (2018) · Colorectal Disease · doi:10.1111/codi.14503 · Cited by 35
Using plasma cell‐free DNA to monitor the chemoradiotherapy course of cervical cancer
Tian, J., Geng, Y., Lv, D., Li, P., Córdova‐Delgado, M., Liao, Y., Tian, X., Zhang, X., Zhang, Q., Zou, K., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32295 · Cited by 35
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Remón, J., García‐Campelo, R., de Álava, E., Vera, R., Rodríguez‐Peralto, J. L., Rodríguez-Lescure, Á., Bellosillo, B., Garrido, P., Rojo, F., & Álvarez-Alegret, R. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02211-x · Cited by 37
Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?
Yuan, Z., Wang, X., Geng, X., Li, Y., Mu, J., Tan, F., Xue, Q., Gao, S., & He, J. (2020) · 癌症：英文版 · doi:10.1002/cac2.12118 · Cited by 34
A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma
Cimmino, F., Lasorsa, V. A., Vetrella, S., Iolascon, A., & Capasso, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.596191 · Cited by 35
Biomarkers in Colorectal Cancer: Actual and Future Perspectives
Lișcu, H.-D., Verga, N. I., Atasiei, D.-I., Badiu, C. D., Dumitru, A. V., Ultimescu, F., Pavel, C. J. V., Stefan, R.-E., Manole, D.-C., & Ionescu, A.-I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111535 · Cited by 35
Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
Vandeputte, C., Kehagias, P., Housni, H. E., Ameye, L., Laes, J., Desmedt, C., Sotiriou, C. P., Deleporte, A., Puleo, F., Geboes, K. P., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24879 · Cited by 34
Circulating cell-free tumor DNA analysis in pediatric cancers
Andersson, D., Fagman, H., Dalin, M. G., & Ståhlberg, A. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.09.003 · Cited by 37
Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
Zhang, C., Yin, S., Tan, Y., Huang, J., Wang, P., Hou, W., Zhang, Z., & Xu, H. (2020) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000663 · Cited by 34
Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer
Boysen, A. K., Pallisgaard, N., Andersen, C. S. A., & Spindler, K. G. (2020) · Acta Oncologica · doi:10.1080/0284186x.2020.1806357 · Cited by 34
The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC
Zhao, X., Dai, F., Mei, L., Huang, D., Shen, X., Zhang, H., She, X., & Ma, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.671963 · Cited by 34
A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice
Kramer, A., Schuuring, E. M. D., Vessies, D. C. L., van der Leest, P., Geerlings, M. J., Rozendal, P., Lanfermeijer, M., Linders, T. C., van Kempen, L. C. L. T., Fijneman, R. J. A., et al. (2022) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2022.10.004 · Cited by 33
Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article
Dong, Q., Chen, C., Hu, Y., Zhang, W., Yang, X., Qi, Y., Zhu, C., Chen, X., Shen, X., & Ji, W. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2274123 · Cited by 35
Liquid biopsy for precision diagnostics and therapeutics
Anitha, K., Posinasetty, B., Kumari, K. N., Chenchula, S., Padmavathi, R., Prakash, S., & Chikatipalli, R. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117746 · Cited by 33
Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid
Otsuji, R., Fujioka, Y., Hata, N., Kuga, D., Hatae, R., Sangatsuda, Y., Nakamizo, A., Mizoguchi, M., & Yoshimoto, K. (2024) · Cancers · doi:10.3390/cancers16051009 · Cited by 37
Circulating Tumor DNA as a Real-Time Biomarker for Minimal Residual Disease and Recurrence Prediction in Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis
Negro, S., Pulvirenti, A., Trento, C., Indraccolo, S., Ferrari, S., Scarpa, M., Urso, E. D. L., Bergamo, F., Pucciarelli, S., Deidda, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062486 · Cited by 37
What We Know About Stage II and III Colon Cancer: It’s Still Not Enough
Puccini, A., Berger, M. D., Zhang, W., & Lenz, H. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0494-5 · Cited by 34
Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma
Park, S. J., Lee, E., Rim, C. H., & Seong, J. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.4.470 · Cited by 33
Development of circulating tumour DNA analysis for gastrointestinal cancers
Nakamura, Y., & Shitara, K. (2020) · ESMO Open · doi:10.1136/esmoopen-2019-000600 · Cited by 33
The study of noninvasive brain stimulation using molecular brain imaging: A systematic review
Tremblay, S., Tuominen, L. J., Zayed, V. K., Pascual‐Leone, Á., & Joutsa, J. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117023 · Cited by 39
Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1
Symonds, E. L., Pedersen, S. K., Yeo, B. S., Naji, H. A., Byrne, S. E., Roy, A. C., & Young, G. P. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13178 · Cited by 33
Ultrastructural localization of the putative precursors of the A4 amyloid protein associated with Alzheimer's disease.
Catteruccia, N., Willingale-Theune, J., Bunke, D., Prior, R., Masters, C. L., Crisanti, A., & Beyreuther, K. T. (1990) · Europe PMC (PubMed Central) · Cited by 33
Tapping into the genome: the role of CSF ctDNA liquid biopsy in glioma
Friedman, J. S., Hertz, C. A. J., Karajannis, M. A., & Miller, A. M. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac034 · Cited by 32
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay
Hashimoto, T., Nakamura, Y., Oki, E., Kobayashi, S., Yuda, J., Shibuki, T., Bando, H., & Yoshino, T. (2024) · International Journal of Clinical Oncology · doi:10.1007/s10147-024-02493-4 · Cited by 32
Circulating tumor DNA for MRD detection in colorectal cancer: recent advances and clinical implications
Ma, D.-N., Gao, X., Wang, L., Yin, H., Feng, L.-H., & Zhu, Y. (2025) · Biomarker Research · doi:10.1186/s40364-025-00796-w · Cited by 35
Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study
Chang, H., Yu, X., Xiao, W., Wang, Q.-X., Zhou, W.-H., Zeng, Z., Ding, P.-R., Li, L., & Gao, Y. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s150367 · Cited by 32
Self-citation
Predictive and therapeutic biomarkers in chimeric antigen receptor T‐cell therapy: A clinical perspective
Mirzaei, H. R., Mirzaei, H., Namdar, A., Rahmati, M., Till, B. G., & Hadjati, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27519 · Cited by 32
The use of PET/MRI for imaging rectal cancer
Hope, T. A., Kassam, Z., Loening, A. M., McNamara, M. M., & Paspulati, R. M. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02089-x · Cited by 32
Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer
Pellini, B., Szymanski, J. J., Chin, R.-I., Jones, P. A., & Chaudhuri, A. A. (2020) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2020.01.005 · Cited by 32
Direct Enhanced Detection of Multiple Circulating Tumor DNA Variants in Unprocessed Plasma by Magnetic-Assisted Bioelectrocatalytic Cycling
Koo, K. M., & Trau, M. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01512 · Cited by 32
Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA
Dudley, J. C., & Diehn, M. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032604 · Cited by 31
ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)
Masfarré, L., Vidal, J., Fernández‐Rodríguez, C., & Montagut, C. O. (2021) · Cancers · doi:10.3390/cancers13122869 · Cited by 33
The Provocative Roles of Platelets in Liver Disease and Cancer
Marie, P. K., Fowlkes, N. W., Afshar‐Kharghan, V., Martch, S. L., Sorokin, A. V., Shen, J. P., Morris, V. K., Dasari, A. N., You, N., Sood, A. K., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.643815 · Cited by 32
PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
Xia, T., Liu, M., Zhao, Q., Ouyang, J., Xu, P., & Chen, B. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04125-5 · Cited by 31
Postoperative circulating tumor DNA combined with consensus molecular subtypes can better predict outcomes in stage III colon cancers: A prospective cohort study
Li, Y., Mo, S., Zhang, L., Ma, X., Hu, X., Huang, D., Lu, B., Luo, C., Peng, H., Cai, S., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.04.010 · Cited by 32
Methylation in cell-free DNA for early cancer detection
de la Cruz, F. F., & Corcoran, R. B. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy134 · Cited by 33
Liquid biopsies in gastrointestinal malignancies: when is the big day?
Lopez, A., Harada, K., Kaya, D. M., Dong, X., Song, S., & Ajani, J. A. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1403320 · Cited by 32
Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies
McEvoy, A. C., Pereira, M. R., Reid, A. L., Pearce, R. L., Cowell, L., Al‐Ogaili, Z., Khattak, M. A., Millward, M., Meniawy, T. M., Gray, E. S., et al. (2019) · Oncotarget · doi:10.18632/oncotarget.26451 · Cited by 31
Application of Microfluidic Chips in Separation and Analysis of Extracellular Vesicles in Liquid Biopsy for Cancer
Jin, L., Pang, J., Chen, Y., Dong, Q., Sheng, J., Luo, Y., Lu, Y., Lin, B., & Liu, T. (2019) · Micromachines · doi:10.3390/mi10060390 · Cited by 33
Multimodality treatment for localized gastric cancer: state of the art and new insights
Petrillo, A., & Smyth, E. C. (2020) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000630 · Cited by 31
Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer
To, Y. H., Degeling, K., Kosmider, S., Wong, R., Lee, M., Dunn, C., Gard, G., Jalali, A., Wong, V., IJzerman, M. J., et al. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01047-0 · Cited by 32
Self-citation
The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV ‐associated tumors: A review
Sivars, L., Pálsdóttir, K., Guterstam, Y. C., Falconer, H., Hellman, K., & Tham, E. (2022) · International Journal of Cancer · doi:10.1002/ijc.34333 · Cited by 34
Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine
Arechederra, M., Avila, M. A., & Berasain, C. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0009 · Cited by 31
Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
Xu, Y., Cai, J., Zhong, K., Wen, Y., Cai, L., He, G., Liao, H., Zhang, C., Fu, S., Chen, T., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1119744 · Cited by 33
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer
Kramer, A., Greuter, M. J. E., Schraa, S. J., Vink, G. R., Phallen, J. A., Velculescu, V. E., Meijer, G. A., van den Broek, D. A., Koopman, M., Roodhart, J. M. L., et al. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241266164 · Cited by 32
Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer
Martín-Arana, J., Gimeno-Valiente, F., Henriksen, T. V., García-Micó, B., Martínez-Castedo, B., Gambardella, V., Martínez‐Ciarpaglini, C., Lucas, B. P.-D., Huerta, M., Camblor, D. G., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-00960-z · Cited by 36
Feasibility of monitoring advanced melanoma patients using cell‐free DNA from plasma
Gangadhar, T. C., Savitch, S. L., Yee, S. S., Xu, W., Huang, A. C. C., Harmon, S., Lieberman, D. B., Soucier, D., Fan, R., Black, T. A., et al. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12623 · Cited by 39
Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
Sun, X., Huang, T., Cheng, F., Huang, K., Liu, M., He, W., Li, M., Zhang, X., Xu, M., Chen, S., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.7837 · Cited by 30
Technical progress in circulating tumor DNA analysis using next generation sequencing
Bai, Y., Wang, Z., Liu, Z., Liang, G., Gu, W., & Ge, Q. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.101480 · Cited by 30
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors
Partelli, S., Andreasi, V., Muffatti, F., Lena, M. S., & Falconi, M. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08425-6 · Cited by 30
Microfluidic Chip-Based Cancer Diagnosis and Prediction of Relapse by Detecting Circulating Tumor Cells and Circulating Cancer Stem Cells
Cho, H., Choi, J., Lim, J., Lee, S., & Choi, J.-W. (2021) · Cancers · doi:10.3390/cancers13061385 · Cited by 30
Serial Circulating Tumor DNA Detection Using a Personalized, Tumor-Informed Assay in Esophageal Adenocarcinoma Patients Following Resection
Ococks, E., Sharma, S., Ng, A. W. T., Aleshin, A. A., Fitzgerald, R. C., & Smyth, E. C. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.011 · Cited by 29
Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review
Schraa, S. J., van Rooijen, K. L., Koopman, M., Vink, G. R., & Fijneman, R. J. A. (2022) · Cancers · doi:10.3390/cancers14092218 · Cited by 29
Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients
Vessies, D. C. L., Schuurbiers, M. M. F., van der Noort, V., Schouten, I., Linders, T. C., Lanfermeijer, M., Ramkisoensing, K. L., Hartemink, K. J., Monkhorst, K., van den Heuvel, M. M., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13267 · Cited by 30
Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)
Chakrabarti, S., Kasi, A., Parikh, A. R., & Mahipal, A. (2022) · Cancers · doi:10.3390/cancers14133078 · Cited by 32
Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons
Bounajem, M. T., Karsy, M. J., & Jensen, R. L. (2020) · Neurosurgical FOCUS · doi:10.3171/2019.9.focus19712 · Cited by 30
Stable, simultaneous and proportional 4-DoF prosthetic hand control via synergy-inspired linear interpolation: a case series
Lukyanenko, P., Dewald, H. A., Lambrecht, J., Kirsch, R. F., Tyler, D. J., & Williams, M. R. (2021) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-021-00833-3 · Cited by 27
Principles of digital sequencing using unique molecular identifiers
Andersson, D., Kebede, F. T., Escobar, M., Österlund, T., & Ståhlberg, A. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101253 · Cited by 30
Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans
Li, Y., Heer, A. K., Sloane, H. S., Edelstein, D. L., Tie, J., Gibbs, P., & Barzi, A. (2024) · JAMA Health Forum · doi:10.1001/jamahealthforum.2024.1270 · Cited by 32
Self-citation
Bridging Discovery and Treatment: Cancer Biomarker
Liu, H., Karsidag, I., Golin, R., & Wu, G. (2025) · Cancers · doi:10.3390/cancers17223720 · Cited by 35
Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC
Jiang, T., Li, X., Wang, J., Su, C., Han, W., Zhao, C., Wu, F., Gao, G., Li, W., Chen, X., et al. (2017) · Theranostics · doi:10.7150/thno.21687 · Cited by 29
The Utility of Liquid Biopsy in Central Nervous System Malignancies
Nevel, K. S., Wilcox, J. A., Robell, L., & Umemura, Y. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0706-x · Cited by 29
Designing circulating tumor DNA-based interventional clinical trials in oncology
Araújo, D. V., Bratman, S. V., & Siu, L. L. (2019) · Genome Medicine · doi:10.1186/s13073-019-0634-x · Cited by 29
Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer:Post hocAnalysis of the MOSAIC and PETACC-8 Trials
Auclin, É., Taı̈eb, J., Lepage, C., Aparicio, T., Faroux, R., Mini, E., Folprecht, G., Salazar, R., Benetkiewicz, M., Banzi, M. C., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0867 · Cited by 30

Authors: Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., Kosmider, S., Skinner, I., Wong, R., Steel, M., Tran, B., Desai, J., Jones, I., Haydon, A., Hayes, T., Price, T. J., Strausberg, R. L., Diaz, L. A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., & Gibbs, P.
Affiliations: The University of Melbourne (AU)
Howard Hughes Medical Institute (US)
Johns Hopkins University (US)
PapGene (United States) (US)
The Royal Melbourne Hospital (AU)
Western Health (AU)
Walter and Eliza Hall Institute of Medical Research (AU)
Eastern Health (AU)
The Alfred Hospital (AU)
Department of Medical Oncology, Warrnambool Hospital, Warrnambool, Victoria 3280, Australia.
Department of Medical Oncology, Queen Elizabeth Hospital and University of Adelaide, Adelaide, South Australia 3174, Australia.
Ludwig Cancer Research (US)
Corresponding author: Tie, Jeanne
Wang, Yuxuan
Vogelstein, Bert
Gibbs, Peter
ORCID: Tie, Jeanne
Wang, Yuxuan
Tomasetti, Cristian
Li, Lu
Springer, Simeon
Silliman, Natalie
Tacey, Mark
Wong, Hui-Li
Christie, Michael
Kosmider, Suzanne
Skinner, Iain
Wong, Rachel
Steel, Malcolm
Tran, Ben
Desai, Jayesh
Jones, Ian
Haydon, Andrew
Hayes, Theresa
Diaz, Luis A.
Papadopoulos, Nickolas
Kinzler, Kenneth W.
Vogelstein, Bert
Gibbs, Peter
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2016-07-06
Volume: 8
Issue: 346
Pages: 346ra92-346ra92
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.aaf6219
PMC: PMC5346159
OpenAlex: W2460179076
Cited by: 1,492
References: 43
Citations by year: 2026: 119 · 2025: 131 · 2024: 130 · 2023: 181 · 2022: 173 · 2021: 197 · 2020: 173 · 2019: 146 · 2018: 134 · 2017: 90 · 2016: 14
FWCI: 53.29
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.sciencemag.org/about/science-licenses-journal-article-reuse (vor, 365 d)
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders: Virginia and D.K. Ludwig Fund for Cancer Research
Conrad N. Hilton Foundation
Sol Goldman Sequencing Facility at Johns Hopkins
NIH (CA57345, R37-CA43460, U01-CA152753, P30-CA006973)
Victorian Cancer Agency
Victorian Cancer Agency Clinical Research Fellowship
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords: circulating tumor DNA, stage II colon cancer, minimal residual disease, tumor recurrence prediction, adjuvant chemotherapy, liquid biopsy, recurrence-free survival, plasma biomarkers, resected colon cancer
MeSH terms: Circulating Tumor DNA, Colonic Neoplasms, Humans, Neoplasm Recurrence, Local, Neoplasm Staging, Prospective Studies, Proportional Hazards Models, Neoplasm, Residual, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks